endometriosis page header
endometriosis info ordering endometriosis endometriosis news espanol endometriosis Phisicians Resources ordering endometriosis
    endometriosis logo
endometriosis links endometriosis links endometriosis links endometriosis links endometriosis links endometriosis links endometriosis links endometriosis links endometriosis links endometriosis links endometriosis links endometriosis links endometriosis links endometriosis links endometriosis links endometriosis links endometriosis links endometriosis links endometriosis links endometriosis links endometriosis links endometriosis links endometriosis links Buy Prosirona
     

Endometriosis Association
Online CME Course EA-CME-001

Endometriosis: The Mysteries Are Unraveling—New Clinical and Scientific Insights

About the Course
Welcome! Do you find the disease of endometriosis to be a puzzling diagnosis with limited effective treatment options? If so, the presentations in this course from renowned experts are uniquely designed to highlight for clinicians the most recent perspectives and findings in endometriosis research and treatment. Their presentations cover current knowledge of the environmental, immune, and endocrine components of the disease, risks for autoimmune diseases and cancer, and the most current surgical, medical, immune, and integrative therapies. These presentations were part of the CME Clinician Program at the Endometriosis Association 25th Anniversary Conference in Milwaukee, Wisconsin, USA, October 7, 2005.
 
Faculty and Program

Understanding the Role of Hormonally – Active Chemicals and Their Impact on Your Patients and Their Families
Ted Schettler, M.D., M.P.H.
Science Director, Science and Environmental Health Network; Chair, Science Work Group, Collaborative on Health and the Environment
Dr. Schettler has published and spoken widely about the impact of environmental contaminants on children’s health and development.

*Dr. Schettler does not have any affiliations with commercial supporters to disclose.

Endometriosis and Cancer: What the Practitioner Needs to Know
Louise Brinton, Ph.D.
Chief, Hormonal & Reproductive Epidemiology Branch, National Cancer Institute
Dr. Brinton has conducted the groundbreaking research on endometriosis and the higher risks for certain cancers, including ovarian and breast.

*Dr. Brinton does not have any affiliations with commercial supporters to disclose.

What Women With Endometriosis Want When They Go to Their Doctors
Mary Lou Ballweg
Cofounder, President/Executive Director, Endometriosis Association
Ms. Ballweg is internationally recognized for her pioneering efforts in endometriosis research, education, and patient advocacy.

*Ms. Ballweg does not have any affiliations with commercial supporters to disclose.

Safe and Effective Surgery for Endometriosis, Including Detection and Intervention for Ovarian Cancer
Camran Nezhat, M.D.
Professor, Surgery, Ob/Gyn, Director, Center for Special Minimally Invasive Surgery, Stanford University; Endometriosis Association Lifetime Member, Advisor
Dr. Nezhat is a world-renowned endometriosis surgery pioneer who has developed many of the techniques of operative laparoscopy.

*Dr. Nezhat does not have any affiliations with commercial supporters to disclose.

New Medical Therapies for Endo – Estrogen Receptor Beta Agonists, Angiogenesis Inhibitors/Statins, Selective Progesterone Modulators, and More
William Schlaff, M.D.
Professor, Chief, Department of Obstetrics and Gynecology, University of Colorado Health Sciences Center; Endometriosis Association Advisor
Dr. Schlaff is known for his in-depth experience in clinical trials of medical therapies for endometriosis.

*Dr. Schlaff is a consultant for Pfizer and receives grants/research support from Pfizer and Organon.

Treating the Big Picture of Endometriosis
Deborah Metzger, M.D., Ph.D.
Harmony Women’s Health Center, Los Altos, CA; Endometriosis Association Advisor
Dr. Metzger is a prominent integrative medicine specialist, combining medical and surgical therapies with complementary approaches.

*Dr. Metzger does not have any affiliations with commercial supporters to disclose.
 
Course Objectives
Upon completion of this course, participants will be able to:
  1. Better understand the role of hormonally-active chemicals in humans, with consideration given to women who are prone to endometriosis and related illnesses.

  2. Update their knowledge of cancers prevalent in women with endometriosis and how to assess risk.

  3. Enhance their knowledge of diagnosis and treatment approaches for endometriosis with new insights on the disease and the patient experience of it.

  4. Update their knowledge of new surgical techniques in the treatment of endometriosis, detection, and intervention.

  5. Describe the variety of medical therapies available—including the newest—for the treatment of endometriosis.

  6. Consider treatment of the immune components of endometriosis.
endometriosis button
This activity has been made possible through an unrestricted educational grant from Wyeth Incorporated and as an online offering through an unrestricted educational grant from Pfizer. This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the Association of Reproductive Health Professionals (ARHP) and the Endometriosis Association. ARHP is accredited by ACCME to provide this continuing medical education activity for 2 credit hours in Category 1 of the Physician’s Recognition Award of the American Medical Association.
Endometriosis Association
8585 N. 76th Place
Milwaukee, WI 53223 USA
phone 414.355.2200
fax 414.355.6065
©2005 Endometriosis Association
All rights reserved.